CIK 0001840706 · Accelerated filer<br>Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41 21 694 10 60
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- Open-market buys, last 90 days
- $278,388
- in 2 filings
- Open-market sales, last 90 days
- $1,679,030
- in 28 filings, $1.6M under 10b5-1 plans
Net −$1,400,642. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-07 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −17,685 | $5.28 | $93K | 3,541,122 |
| 2026-07-06 | CARDOZA GEORGE Chief Financial Officer | Sale 10b5-1 | −1,592 | $5.29 | $8K | 309,092 |
| 2026-07-06 | Valente Manuela Chief People Officer | Sale 10b5-1 | −4,241 | $5.05 | $21K | 210,450 |
| 2026-07-06 | Verma Abhimanyu Chief Technology Officer | Sale 10b5-1 | −5,285 | $5.10 | $27K | 192,171 |
| 2026-07-06 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −7,393 | $5.17 | $38K | 614,887 |
| 2026-07-06 | Muken Ross Chief Executive Officer | Sale 10b5-1 | −9,838 | $5.22 | $51K | 670,651 |
| 2026-07-06 | Puylaert Kevin Chief Sales Officer | Sale | −138 | $5.03 | $693 | 148,026 |
| 2026-07-06 | Puylaert Kevin Chief Sales Officer | Sale | −47 | $5.03 | $236 | 147,979 |
| 2026-07-06 | Puylaert Kevin Chief Sales Officer | Sale | −31 | $5.09 | $158 | 147,948 |
| 2026-07-06 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −7,393 | $5.16 | $38K | 233,387 |
| 2026-07-06 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −22,486 | $5.26 | $118K | 3,558,807 |
| 2026-06-30 | Camblong Jurgi Executive Chairman | Option exercise 10b5-1 | +45,419 | $3.16 | $144K | 3,646,562 |
| 2026-06-30 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −45,419 | $6.14 | $279K | 3,601,143 |
| 2026-06-30 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −19,650 | $6.02 | $118K | 3,581,493 |
| 2026-06-30 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −200 | $6.30 | $1K | 3,581,293 |
| 2026-06-30 | Camblong Jurgi Executive Chairman | Option exercise · Share Option (Right to Buy) 10b5-1 | −45,419 | 4,581 | ||
| 2026-06-29 | Camblong Jurgi Executive Chairman | Option exercise 10b5-1 | +18,060 | $3.16 | $57K | 3,619,553 |
| 2026-06-29 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −18,060 | $5.87 | $106K | 3,601,493 |
| 2026-06-29 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −350 | $6.00 | $2K | 3,601,143 |
| 2026-06-29 | Camblong Jurgi Executive Chairman | Option exercise · Share Option (Right to Buy) 10b5-1 | −18,060 | 50,000 |
Page 4 of 8 · 157 trades